Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Antipsychotics increase death risk in elderly

MagazineJune 2005 (Vol. 16 Issue 3)Antipsychotics increase death risk in elderly

The maverick practice of off-label prescribing - giving drugs for unapproved conditions/patients - is once again in the limelight

The maverick practice of off-label prescribing - giving drugs for unapproved conditions/patients - is once again in the limelight. The US Food and Drug Administration (FDA) has issued a warning against using 'atypical antipsychotics' to treat behavioural disorders in elderly patients after 15 clinical trials showed that older patients with dementia, treated with either olanzapine, aripiprazole, risperidone or quetiapine, were nearly twice as likely to die compared with those given a placebo. The specific causes of death were mainly heart-related events (for example, heart failure or sudden death) or infections (mostly pneumonia). This class of drugs is only approved for schizophrenia (www.fda.gov/cder/drug/advisory/antipsychotics.htm).


Tailbone pain

Mitral valve prolapse

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved